‘My old doctor told me there was nothing he could do. He told me it was my fault': Wegovy revolution sees 600% increase among young adults [Fortune]
IQVIA Holdings, Inc. (IQV)
Last iqvia holdings, inc. earnings: 4/28 07:00 am
Check Earnings Report
US:NYSE Investor Relations:
ir.iqvia.com
Company Research
Source: Fortune
“I was in a really dark place,” says McKenzie, whose weight had climbed to 335 pounds on his 6-foot-1 frame, despite repeated efforts to diet and exercise. “I had given up hope.” But last year, the weight-loss drug Wegovy helped him shed 110 pounds in nine months, making the rural Tennessee teen part of a surge of adolescents and young adults using diabetes and obesity medications known as GLP-1 receptor agonists, new research shows Even as millions of older adults clamor for drugs such as Ozempic and Wegovy, monthly use of the medications soared in people aged 12 to 25. That's according to the new analysis of dispensing records from nearly 94% of U.S. retail pharmacies from 2020 to 2023. The report, published in the journal JAMA on Wednesday, used the IQVIA prescription database to compile the first look at the national uptake of GLP-1 drugs among that age group. Nearly 31,000 children aged 12 to 17 and more than 162,000 people aged 18 to 25 used the medications in 2023 alone,
Show less
Read more
Impact Snapshot
Event Time:
IQV
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
IQV alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
IQV alerts
High impacting IQVIA Holdings, Inc. news events
Weekly update
A roundup of the hottest topics
IQV
News
- $14 Billion Medical Device CRO Market Report by Phase, Service, Device Type, and Region - Forecast to 2030 [Yahoo! Finance]Yahoo! Finance
- IQVIA (IQV) Announces Launch of Trial Technology Platform [Yahoo! Finance]Yahoo! Finance
- Adalvo Secures First EU Generic Approval for Liraglutide Pre-Filled Pen [Yahoo! Finance]Yahoo! Finance
- Adalvo Secures First EU Generic Approval for Liraglutide Pre-Filled Pen [Financial Post (Toronto, Ontario, Canada)]Financial Post
- Global Healthcare Marketing & Communications Market Report 2024-2030: Porter's Five Forces, Value Chain, Pricing, Technology, Patent, Trade, and Regulatory Framework Analysis Featuring 25+ Major Player Profiles [Yahoo! Finance]Yahoo! Finance
IQV
Earnings
- 5/2/24 - Beat
IQV
Sec Filings
- 5/17/24 - Form 3
- 5/10/24 - Form 8-K
- 5/9/24 - Form 4
- IQV's page on the SEC website